Colorectal Cancer: Epidemiology, Risk Factors, and Prevention
Cancers,
Journal Year:
2024,
Volume and Issue:
16(8), P. 1530 - 1530
Published: April 17, 2024
Colorectal
cancer
(CRC)
is
the
third
most
common
and
second
cause
of
mortality
worldwide.
There
are
disparities
in
epidemiology
CRC
across
different
populations,
probably
due
to
differences
exposure
lifestyle
environmental
factors
related
CRC.
Prevention
effective
method
for
controlling
Primary
prevention
includes
determining
avoiding
modifiable
risk
(e.g.,
alcohol
consumption,
smoking,
dietary
factors)
as
well
increasing
protective
physical
activity,
aspirin).
Further
studies,
especially
randomized,
controlled
trials,
needed
clarify
association
between
incidence
or
factors.
Detection
removal
precancerous
colorectal
lesions
also
an
strategy
Multiple
factors,
both
at
individual
community
levels
patient
preferences,
availability
screening
modalities,
costs,
benefits,
adverse
events),
should
be
taken
into
account
designing
implementing
programs.
Health
policymakers
consider
best
decision
identifying
starting
age
selection
strategies
target
population.
This
review
aims
present
updated
evidence
on
epidemiology,
Language: Английский
Revealing the association between East Asian oral microbiome and colorectal cancer through Mendelian randomization and multi-omics analysis
Yuheng Gu,
No information about this author
Lai Jiang,
No information about this author
敏之 清水
No information about this author
et al.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Sept. 17, 2024
Background
Colorectal
cancer
(CRC)
poses
a
global
health
threat,
with
the
oral
microbiome
increasingly
implicated
in
its
pathogenesis.
This
study
leverages
Mendelian
Randomization
(MR)
to
explore
causal
links
between
microbiota
and
CRC
using
data
from
China
National
GeneBank
Biobank
Japan.
By
integrating
multi-omics
approaches,
we
aim
uncover
mechanisms
by
which
influences
cellular
metabolism
development.
Methods
We
analyzed
profiles
2017
tongue
1915
saliva
samples,
GWAS
for
6692
cases
27178
controls.
Significant
bacterial
taxa
were
identified
via
MR
analysis.
Single-cell
RNA
sequencing
enrichment
analyses
elucidated
underlying
pathways,
drug
predictions
potential
therapeutics.
Results
19
significantly
associated
CRC.
Protective
effects
observed
like
RUG343
Streptococcus_umgs_2425,
while
HOT-345_umgs_976
W5053_sp000467935_mgs_712
increased
risk.
revealed
key
including
JAK-STAT
signaling
tyrosine
metabolism.
Drug
prediction
highlighted
therapeutics
Menadione
Sodium
Bisulfite
Raloxifene.
Conclusion
establishes
critical
role
of
colorectal
development,
identifying
specific
microbial
linked
further
elucidate
pathways
therapeutics,
providing
novel
insights
personalized
treatment
strategies
Language: Английский
Cell-death induced immune response and coagulopathy promote cachexia in Drosophila
Ankita Singh,
No information about this author
Yanhui Hu,
No information about this author
Raphael Lopes
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 8, 2025
Tumors
can
exert
a
far-reaching
influence
on
the
body,
triggering
systemic
responses
that
contribute
to
debilitating
conditions
like
cancer
cachexia.
To
characterize
mechanisms
underlying
tumor-host
interactions,
we
utilized
BioID-based
proximity
labeling
method
identify
proteins
secreted
by
Yki
act
adult
Drosophila
gut
tumors
into
bloodstream/hemolymph.
Among
major
identified
are
coagulation
and
immune-responsive
factors
wasting
phenotypes
associated
with
tumors.
The
effect
of
innate
immunity
is
mediated
NFκB
transcription
Relish,
dorsal,
Dif,
which
in
turn
upregulate
expression
cachectic
Pvf1,
Impl2,
Upd3.
In
addition,
secrete
Eiger,
TNF-alpha
homolog,
activates
JNK
signaling
pathway
neighboring
non-tumor
cells,
leading
cell
death.
release
damage-associated
molecular
patterns
(DAMPs)
from
these
dying
cells
presumably
amplifies
inflammatory
response,
exacerbating
wasting.
Targeting
pathway,
or
production
could
potentially
alleviate
effects
Language: Английский
Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights
Linda Galasso,
No information about this author
Fabrizio Termite,
No information about this author
Irene Mignini
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(3), P. 368 - 368
Published: Jan. 23, 2025
Fusobacterium
nucleatum,
a
gram-negative
anaerobic
bacterium,
has
emerged
as
significant
player
in
colorectal
cancer
(CRC)
pathogenesis.
The
bacterium
causes
persistent
inflammatory
reaction
the
mucosa
by
stimulating
release
of
pro-inflammatory
cytokines
like
IL-1β,
IL-6,
and
TNF-α,
creating
an
environment
conducive
to
progression.
F.
nucleatum
binds
penetrates
epithelial
cells
through
adhesins
such
FadA,
impairing
cell
junctions
encouraging
epithelial-to-mesenchymal
transition
(EMT),
which
is
associated
with
advancement.
Additionally,
modulates
host
immune
system,
suppressing
activity
conditions
favorable
for
tumor
growth.
Its
interactions
gut
microbiome
contribute
dysbiosis,
further
influencing
carcinogenic
pathways.
Evidence
indicates
that
can
inflict
DNA
damage
either
directly
via
reactive
oxygen
species
or
indirectly
environment.
it
triggers
oncogenic
pathways,
especially
Wnt/β-catenin
signaling
pathway,
promotes
growth
longevity.
Moreover,
alters
microenvironment,
impacting
behavior,
metastasis,
therapeutic
responses.
purpose
this
review
elucidate
molecular
mechanisms
contributes
CRC.
Understanding
these
crucial
development
targeted
therapies
diagnostic
strategies
CRC
nucleatum.
Language: Английский
The Influence of Microorganisms on the Onset and Development of Colorectal Cancer in Humans: A Descriptive Cross-Reference Study
Life,
Journal Year:
2025,
Volume and Issue:
15(3), P. 468 - 468
Published: March 15, 2025
Background:
The
aim
of
this
study
is
to
determine
which
types
microorganisms
influence
the
onset
and
development
colorectal
cancer
(CRC)
in
humans.
Methods:
In
patients
with
CRC,
three
swabs
were
taken
for
microbiological
analysis
during
surgical
removal
cancer:
first
swab
from
surface
healthy
intestinal
mucosa,
second
tumor,
third
middle
tumor
tissue.
Results:
mucosa
colon,
most
prevalent
microorganism
was
Escherichia
coli
at
70.5%,
followed
by
Enterococcus
spp.
(47.7%)
Klebsiella/Enterobacter
(20.5%).
Microbiological
tissue
showed
that
E.
72.7%,
40.9%,
25%,
Pseudomonas
aeruginosa
20%.
center
tissue,
77.3%,
47.7%,
Klebsiella
27%,
18.2%.
Conclusion:
Certain
bacteria
can
emergence
cancer,
while
other
suppress
human
stool
samples
prevent
CRC.
Language: Английский